Spanish Biotech Database

Biotechgate

Biotechgate Global Database › Global Trial › Global Log-in ›

Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry
Results 21 - 40 out of 147 displayed.
« 1 2 3 4 5 6 7 8 »

Novo Nordisk's sales increased by 16% in Danish kroner and by 14% at constant exchange rates (CER) to DKK 33.9 billion in the first three months of 2020

Read more ››

By: GlobenewsWire - 06 May 2020

Three-month interim report (Q1) 2020

Read more ››

By: GlobenewsWire - 06 May 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 05 May 2020

Libtayo® (cemiplimab) shows clinically meaningful and durable responses in second-line advanced basal cell carcinoma

Read more ››

By: GlobenewsWire - 05 May 2020

Sanofi: information concerning the total number of voting rights and shares, March 2020

Read more ››

By: GlobenewsWire - 03 May 2020

Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 30 April 2020

Read more ››

By: GlobenewsWire - 30 Apr 2020

Novo Nordisk A/S – Reduction of the share capital

Read more ››

By: GlobenewsWire - 28 Apr 2020

Novo Nordisk A/S - Articles of Association

Read more ››

By: GlobenewsWire - 28 Apr 2020

Sanofi: Annual General Meeting of April 28, 2020

Read more ››

By: GlobenewsWire - 28 Apr 2020

Sanofi : INFORMATION ON THE FINAL TERMS OF DEPARTURE OF OLIVIER BRANDICOURT, FORMER CHIEF EXECUTIVE OFFICER

Read more ››

By: GlobenewsWire - 28 Apr 2020

Release date of three-month interim report (Q1) 2020 for ALK and audio cast

Read more ››

By: GlobenewsWire - 28 Apr 2020

Sanofi and Regeneron provide update on U.S. Phase 2/3 adaptive-designed trial in hospitalized COVID-19 patients

Read more ››

By: GlobenewsWire - 27 Apr 2020

Sanofi: Phase 3 trial of Libtayo® (cemiplimab) as monotherapy for first-line advanced non-small cell lung cancer stopped early due to highly significant improvement in overall survival

Read more ››

By: GlobenewsWire - 27 Apr 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 27 Apr 2020

ORYZON to Initiate ESCAPE: a Phase II Clinical Trial to Test Efficacy of Vafidemstat in Severely ill COVID-19 Patients

Read more ››

By: GlobenewsWire - 24 Apr 2020

Related companies: Oryzon Genomics, S.A.

Sanofi at forefront of fight against COVID-19 in Q1 2020

Read more ››

By: GlobenewsWire - 24 Apr 2020

FDA approves MenQuadfiTM, the latest innovation in meningococcal (MenACWY) vaccination

Read more ››

By: GlobenewsWire - 24 Apr 2020

Sanofi brain-penetrant BTK inhibitor significantly reduced disease activity in Phase 2 trial in relapsing multiple sclerosis

Read more ››

By: GlobenewsWire - 23 Apr 2020

ALK announces Health Canada approval of ITULATEK SLIT-tablets for the treatment of tree pollen allergy

Read more ››

By: GlobenewsWire - 20 Apr 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 20 Apr 2020

« 1 2 3 4 5 6 7 8 »

Looking for companies outside of Spain?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

May 2020
- 6th Annual Digital Immuno-oncology Innovation Forum
June 2020
- Digital RESI – Three Day Conference
- BIO Digital

Add an Event »

Latest company news

Sanofi announces pricing of Regeneron stock offering
27 May 2020 (GlobenewsWire)

Sanofi: FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 to 11 years with moderate-to-severe atopic dermatitis
26 May 2020 (GlobenewsWire)

Novo Nordisk A/S – Share repurchase programme
25 May 2020 (GlobenewsWire)

Biotechgate database

About Biotechgate
The Spanish Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com